SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-018613
Filing Date
2022-05-18
Accepted
2022-05-18 16:24:32
Documents
2
Period of Report
2022-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1551
2 EX-24 DOCUMENT attachment1.htm EX-24 2344
  Complete submission text file 0000899243-22-018613.txt   5243
Mailing Address C/O AMICUS THERAPEUTICS, INC. 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
HAYDEN DONALD J JR (Reporting) CIK: 0001202285 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40869 | Film No.: 22939418

Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Issuer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences